
CASI Pharmaceuticals CASI
€ 0.82
9.95%
Quartalsbericht 2022-Q3
hinzugefügt 14.11.2022
CASI Pharmaceuticals Betriebsaufwand 2011-2026 | CASI
Betriebsaufwand Jährlich CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 38.9 M | 40.2 M | 26.5 M | 10.8 M | 9.42 M | 7.19 M | 6.52 M | 5.74 M | 5.17 M | 6.51 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.2 M | 5.17 M | 15.7 M |
Betriebsaufwand anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
432 M | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
92.7 M | $ 2.69 | 0.19 % | $ 208 M | ||
|
Ascendis Pharma A/S
ASND
|
338 M | $ 208.25 | -2.36 % | $ 5 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.66 B | - | - | $ 40.3 B | ||
|
Alterity Therapeutics Limited
ATHE
|
16.7 M | $ 3.42 | 6.54 % | $ 8.23 B | ||
|
AgeX Therapeutics
AGE
|
10.1 M | - | -10.17 % | $ 12.2 K | ||
|
Akero Therapeutics
AKRO
|
80.2 M | - | - | $ 3.67 B | ||
|
Aeglea BioTherapeutics
AGLE
|
209 M | - | - | $ 1.01 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.22 M | - | -1.52 % | $ 24.7 M | ||
|
Albireo Pharma
ALBO
|
163 M | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
4.78 M | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
88.2 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
65.4 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
9.57 M | - | -11.43 % | $ 502 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
14 M | $ 4.35 | -7.64 % | $ 9.47 B | ||
|
Applied Molecular Transport
AMTI
|
127 M | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
80 M | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
427 M | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
79.8 M | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
5.21 K | - | -52.27 % | $ 4.45 M | ||
|
AIkido Pharma
AIKI
|
29.7 M | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
629 M | - | - | - | ||
|
Autolus Therapeutics plc
AUTL
|
145 M | $ 1.91 | -2.31 % | $ 487 M | ||
|
ARCA biopharma
ABIO
|
88.1 M | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
24.4 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
141 M | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
512 M | $ 98.56 | -1.52 % | $ 27.2 B | ||
|
AVROBIO
AVRO
|
71.7 M | - | 1083.1 % | $ 745 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
168 M | $ 27.72 | 1.43 % | $ 1.34 B | ||
|
CureVac N.V.
CVAC
|
88.9 M | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
24.6 M | - | 2.71 % | $ 14 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
1.07 B | $ 11.49 | -2.21 % | $ 743 M | ||
|
BioDelivery Sciences International
BDSI
|
106 M | - | -4.8 % | $ 255 M | ||
|
Axon Enterprise
AXON
|
1.18 B | $ 611.74 | -1.48 % | $ 46.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
29.8 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
53.7 M | $ 2.71 | -4.24 % | $ 17 M | ||
|
BeiGene, Ltd.
BGNE
|
390 M | - | 0.49 % | $ 251 B | ||
|
AstraZeneca PLC
AZN
|
17.6 B | $ 94.15 | -1.06 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
28.5 M | - | -9.72 % | $ 5.89 M | ||
|
Acorda Therapeutics
ACOR
|
206 M | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
14.4 M | - | -5.38 % | $ 6.06 M | ||
|
BioVie
BIVI
|
18.1 M | $ 1.3 | -4.07 % | $ 1.92 M | ||
|
Burford Capital Limited
BUR
|
106 M | $ 9.29 | -0.05 % | $ 1.51 B | ||
|
Berkeley Lights
BLI
|
152 M | - | -7.31 % | $ 87 M | ||
|
Biogen
BIIB
|
5.39 B | $ 185.27 | -0.88 % | $ 27 B | ||
|
Abeona Therapeutics
ABEO
|
50.6 M | $ 5.1 | -2.39 % | $ 109 M | ||
|
bluebird bio
BLUE
|
854 M | - | - | $ 546 M | ||
|
ADiTx Therapeutics
ADTX
|
27.4 M | $ 0.84 | -0.24 % | $ 11.1 K | ||
|
Advaxis
ADXS
|
22 M | - | -9.65 % | $ 45.9 M |